Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Picard Medical (PMI) Asset Writedowns and Impairment (2024 - 2026)

Picard Medical posted quarterly Asset Writedowns and Impairment of $180000.0 for Q1 2026, down 43.57% year-on-year from $319000.0 in Q1 2025, and up 181.82% on a QoQ basis from -$220000.0 in Q4 2025.

Picard Medical (PMI) has 3 years of Asset Writedowns and Impairment data on file, last reported at $180000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 43.57% year-over-year to $180000.0; the trailing twelve-month figure through Mar 2026 stood at -$176000.0 (changed N/A YoY), and the FY2025 full-year result was $423000.0, up 291.67% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $180000.0, up from -$220000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $319000.0 in Q1 2025 and bottomed at -$455000.0 in Q4 2024.
  • The 3-year median for Asset Writedowns and Impairment is -$20000.0 (2025), against an average of -$44000.0.
  • The widest annual swing landed in 2025, when Asset Writedowns and Impairment jumped 51.65%; it then slumped 43.57% in 2026.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at -$455000.0 in 2024, then soared by 51.65% to -$220000.0 in 2025, then surged by 181.82% to $180000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $180000.0 (Q1 2026), -$220000.0 (Q4 2025), and $319000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 180,000.00
Mar 31, 2026 180,000.00
Dec 31, 2025 -220,000.00
Dec 31, 2025 -220,000.00
Dec 31, 2024 -455,000.00
Dec 31, 2024 -455,000.00